Last edition
News about "Contract Development and Manufacturing Organisatio"
Siegfried Expands U.S. Manufacturing Capacity with Acquisition of Two Facilities
Siegfried, the Switzerland-based contract development and manufacturing organisation (CDMO), is expanding its manufacturing presence in the United States through the acquisition of two pharmaceutical production facilities.
Contract Development And Manufacturing Organisatio | 28/01/2026 | By Darshana | 161
Hikal Opens New High Potency API Lab in Pune
Hikal Ltd., a preferred long-term partner to leading global life sciences companies, has inaugurated its state-of-the-art High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory at the company’s Integrated Innovation Centre in Pune.
Contract Development And Manufacturing Organisatio | 13/10/2025 | By Darshana | 244
NextPharma to Sell Healthcare Logistics Business to Cencora
European pharmaceutical contract development and manufacturing organisation (CDMO) NextPharma has signed an agreement with Cencora, a US-based pharmaceutical solutions company, to sell its healthcare logistics services arm, NextPharma Logistics GmbH.
Contract Development And Manufacturing Organisatio | 13/10/2025 | By Dineshwori | 554
FUJIFILM Opens Commercial-Scale Cell Culture Manufacturing Site in North Carolina
FUJIFILM Biotechnologies recently inaugurated its new manufacturing facility in Holly Springs, North Carolina, marking the addition to its global network. The company stated that the site ranks among the largest commercial-scale cell culture biomanufacturing facilities in North America.
Contract Development And Manufacturing Organisatio | 30/09/2025 | By Dineshwori | 215
Bionova Scientific, a full-service biologics contract development and manufacturing organisation (CDMO) and subsidiary of Asahi Kasei, has inaugurated a 10,000-square-foot plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
Contract Development And Manufacturing Organisatio | 13/08/2025 | By Darshana | 279
Laurus Labs Posts Strong Q1 FY26 Results With 31 Percent Revenue Growth
Laurus Labs has reported strong financial results for the first quarter of FY26, with consolidated revenues reaching INR 1,570 crore—a 31 percent year-on-year increase.
Contract Development And Manufacturing Organisatio | 26/07/2025 | By Dineshwori | 1252
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy